Skip to main content
< Back to news
Foto de grup de la delegació catalana que va visitar Massachusetts.

Mind the Byte and Sequentia take part in a trade mission in Massachusetts

Mind the Byte and Sequentia Biotech, both based at the Barcelona Science Park (PCB), have been two of the 10 Catalan companies that participated last week in a trade mission in the state of Massachusetts (US) to search for business opportunities in the fields of digital health and big data applied to life sciences. The trade mission was organized by the Government of Catalonia through ACCIÓ, the agency for business competitiveness, and Biocat coinciding with Bio-IT World Conference & Expo, one of the largest and most important events in the US in the field of ICTs in the health sector.  


As part of the Bio IT World, which brought together more than 3,000 companies and professionals from 30 countries in Boston- the10 Catalan companies that formed part of the mission had the opportunity to present their projects to US investment funds agents to seek funding and find new business partners in order to internationalize their technology. The event was organized in collaboration with Venture Cafe, a foundation that acts as a connector between the agents of the innovation ecosystem of Boston. About fifty bilateral meetings were also held between Catalan companies and other US companies and international organizations who attended the conference.

The state of Massachusetts is considered the region with the highest rates of innovation in the United States, with one of the highest expenditure ratios of R & D and a strong concentration of top leading universities. Taking advantage of the participation at the Boston event, the Catalan delegation visited the  Massachusetts Institute of Technology (MIT) and held meetings with representations from of one the most important business accelerators in the US, MassChallange, an organization that currently includes 1,600 start-ups from 50 countries. 

“Participating in this mission has enabled us to make a first contact with the ecosystem of Massachusetts and talk with potential partners, customers and investors. The US market is the largest and most mature for a company like ours who offer disruptive technology for computational drug design. The pitch session, organized by the office of ACCIÓ in Boston allowed us to assess the interest raised in the territory and gladly, the response was very positive,” says Alfons Nonell -Canal, founder and CEO of Mind the Byte.

For Walter Sanseverino, founder and CEO of Sequentia Biotech, the experience has been very stimulating. “After my pitch I have had very positive feedback on the activity of Sequentia: creating our own know-how to provide and support innovation to the world of scientific research in a sustainable and affordable fashion was certainly gratifying. The interest raised by our business model, which pursues both profitability and improving human health and environmental conservation, encourage us to continue our commitment to expand and strengthen our project of social entrepreneurship,” stated Walter Sanseverino, founder and CEO of Sequentia Biotech.